1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Biobanking for Medicine: Technology, Industry and Market 2015-2025

Report Details
Biobanks – How to Discover Trends, R&D and Sales Forecasts, Helping Your Influence
Are you interested in the future of medical biobanking? If so, now gain technological and commercial predictions from 2015. You will stay ahead with market data, benefiting your authority. There you can explore trends in research and development, results, opportunities and revenue forecasts.

The new study by visiongain shows you what’s possible for biobanking and associated technology to improve healthcare. Avoid missing out. Instead find sales prospects for the biomedical industry and market, discovering expected trends, progress and financial gains.

Biobank services and technology hold great influence on drug discovery and development. That importance increases from 2015. Discover why and how, seeing what’s possible.

Potential of those biorepository technologies and facilities – explore what’s happening
In medical research those biostorage systems form an important resource. They support fields including genomics and personalised medicine, letting companies harness samples.

Our report’s purpose is showing you the commercial potential in storing human biological samples for use in research and therapies, including conserving stem cells.

Please read on to explore those technologies and services for human medicine, finding what influences that market and its predicted results.

Forecasts and other information showing lucrative possibilities for biorepositories
Our study gives sales predictions to 2025 at overall world, submarket and national level. You also get sample unit predictions. For biosample and biospecimen storage, especially for pharmaceutical R&D, you will discover where applications, needs, demand and money lie.

Why struggle to find information or miss data you need on medical biopreservation? Besides revenue forecasting, our new analysis shows you results, growth rates and market shares.

There you can explore those technologies for medical R&D – especially applications suiting drug companies. You will also discover 72 tables, 73 charts and two interviews with other authorities on that biosample preservation for analytical use.

Though no such study covers everything, the following sections explain how our new investigation can benefit your work.



Forecasting of the world market and its segments – what’s likely to happen?
What’re the secrets of that biostorage progress? Discover in our report overall world revenue to 2025, with discussions, for storing human cell, tissue and fluid samples.

So help your research, analyses and decisions on storage of human biological samples (HBS). As someone with authority, benefit your reputation for technological and commercial insight.

Also find individual revenue predictions to 2025 for nine submarkets at world level:
- Biobanking for research
- Biobanking for therapeutic uses.

The survey also forecasts the number of samples stored in those two fields. And it gives biobanking revenue forecasting to 2025 by research application:
- Human tissues – also with sub-forecasts for public sector and commercial uses
- Stem cells
- Other biological sample banking applications – inc. DNA and body fluids.

And that analysis predicts stem cell banking revenues to 2025 for therapeutic uses:
- Umbilical cord stem cell banking
- Adult stem cell banking.

You will also receive forecasts to 2025 for the number of samples banked for research and therapeutic applications.

In our study you assess outlooks for sales expansion, hearing where you could gain. That work explores competition and demand, showing technological and commercial possibilities.

So hear what’s happening. You also investigate geographical revenue potentials.

Biostorage needs in leading national markets – what outlooks for demand, sales and provision?
In developed and developing countries, opportunities for companies providing biorepository facilities, products, services, consumables and technology will expand from 2015. See where, exploring the commercial gains possible.

Our analyses show you individual revenue forecasts to 2025 for 12 leading national biobanking markets:
- The United States (US)
- Japan
- Germany, France, The UK, Italy, Spain (EU5 countries) and The Netherlands
- Brazil, Russia, India and China (BRIC nations).

There discover countries with the highest sales, demand and potential expansion of usage and revenues. That way you investigate progress, needs, opportunities and competitors. And you see the gains possible, finding how you could expand business.

Also what events, challenges and advances in technology affect biorepositories?

Forces influencing suppliers and users of those biomedical resources and libraries
Our new study explores issues, events and contributions affecting that industry and market from 2015, including these influences:
- Guidelines, research and medical ethics, standards (e.g. GLP), legislation, regulations and governmental funding for that biopreservation, inc. HIPAA amendments
- Systems for cryopreservation, biobank networks and biobanking infrastructure
- Facilities, freezers, operations software, consumables and services
- Biobanking in research, drug discovery and development, inc. biomarkers and personalised medicine
- Uses in therapeutics, clinical trials and genome-wide association studies (GWAS).

And you explore these forces, among others:
- Numbers and geographical distribution of biobanks
- Umbilical cord blood banking and induced pluripotent stem cells (iPSCs)
- RFID, tagging technology and laboratory information management systems (LIMS)
- Technologies and services aiding genetic epidemiology studies and understanding of disease pathways
- Automated liquid handling systems, aliquotting and automation in DNA isolation
- Biobanking services – sample storage, tracking, management and transport of human biological samples.

There discover what’s happening to benefit human healthcare, also gaining feel for challenges, trends and outlooks.

That way you will find what stimulates and restrains organisations performing and helping that biosample preservation, affecting their results and those of clients.

Technologies and applications for biobanks – top organisations and 2019 market value
What’s possible? Our study predicts the overall world market will generate $25bn in 2019. Rising demand for biobanked samples for use by pharmaceutical companies in preclinical research most stimulates that market. So explore the high, rising revenues possible to 2025.

And our analysis shows activities of biobanks, including these organisations:
- Stemgent
- Biopta
- BioServe
- Coriell Institute for Medical Research
- Cord Blood America
- Cryo-Cell International.

And other companies, including these:
- China Cord Blood Corp
- LifebankUSA
- ViaCord
- Cord Blood Registry
- Biogenea Pharmaceuticals
- StemLife
- NeoStem.

You assess competitors in that field. You also get interviews with two organisations – 3C-R and UK ME/CFS Biobank. So avoid missing out in knowledge. See what other authorities do, say and think, helping your work.

Ways Biobanking for Medicine: Technology, Industry and Market 2015-2025 helps
In these five main ways, our new investigation helps you get recognition for insight, saving time and benefiting your authority:
- Revenues for biobanking, to 2025, at world level and for 9 submarkets – explore prospects for design, production, sales, marketing, demand and spending
- Forecasts, to 2025, for 12 countries in the Americas, Europe and Asia – assess developed and developing national markets for demand and predicted revenues
- Prospects for established organisations, rising companies and new entrants – examine service and product portfolios, results, strategies and outlooks for success
- Analysis of what stimulates and restrains that industry’s participants – investigate challenges, strengths and competition affecting organisations’ results
- Interviews with experts – discover what other authorities on that field think, say and do, helping you stay ahead in technological, medical and commercial knowledge.

This report, by visiongain’s UK-based analysts, gives knowledge to benefit your research, analyses, plans, decisions and proposals. You will get data leading companies depend on.

Information there found nowhere else, helping your searches, analyses and planning
An off-the-shelf report can’t answer every question, though our work explains that industry’s structures, outlooks and potentials. That’s our purpose, helping you stay ahead.

And our analyses give independent data. There you will receive competitive intelligence found only in this study, finding where progress, money and opportunities lie. See what the future holds.

With that research and analysis you’re less likely to fall behind in knowledge or miss opportunity. See how you could save time and effort. The report will benefit your plans, decisions and presentations, helping you gain competitive advantages and recognition.

Trying our study now lets you discover biobanking opportunities and predictions
Stay ahead with market data. Our new investigation is for everyone analysing medical biotechnology and pharmaceutical R&D. For storing those biological samples you will see trends, opportunities and revenue prospects. So avoid missing out – please get that report here now.

Table Of Contents

Biobanking for Medicine: Technology, Industry and Market 2015-2025
Table of Contents
1. Report Overview
1.1 Biobanking for Medicine: World Market Review 2014
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analysis
1.5 Who is This Study For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to Biobanking and its Applications
2.1 The Human Tissue Banking Market - Our Definition
2.2 The Stem Cell Banking Market - Our Breakdown
2.3 What is Biobanking?
2.4 Main Features of Biobanks
2.5 What Processes are Involved in Biobanking?
2.6 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.6.1 Volunteer Group: General vs. Disease Population
2.6.2 Ownership Structure: Public vs. Private
2.7 The Guidelines and Standards for Biobanking
2.8 Laws and Regulations for Biobank-Based Research
2.8.1 HIPAA Amendments
2.9 Biobanking and the Pharmaceutical Industry
2.9.1 Biobanking in Research, Drug Discovery and Development
2.9.1.1 Biobanking - Facilitates Genetic Epidemiology Studies
2.9.1.2 Novel Drug Discovery through Better Understanding of Disease Pathways
2.9.1.3 Biomarker Discovery in Drug Development
2.9.2 Biobanking for Therapeutic Purposes
2.9.3 Biobanking in Clinical Trials
3. Biobanking for Medicine: World Market 2015-2025
3.1 The World Biobanking for Medicine Market in 2014
3.2 Biobanking for Medicine: Research vs. Therapeutics in 2019 and 2025
3.3 World Biobanking for Medicine Market: Overarching Revenue Forecast 2015-2025
3.4 Biobanks Stored Around 1.3 Billion Specimens in 2014
3.5 The Biobanking for Medicine Market by Sector: Grouped Revenue Forecasts 2015-2025
3.6 Biobanking for Research: Mostly Non-Profit
3.6.1 Biobanking for Research: Revenue Forecast 2015-2025
3.6.2 Driving Forces Outweigh Restraints on the Biobanking Industry for Research
3.7 Biobanking for Future Therapeutic Use: Is It Too Commercial?
3.7.1 Arguments against Commercial Stem Cell Banking for Therapeutic Uses
3.7.2 Biobanking for Future Therapeutic Use: Revenue Forecast 2015-2025
3.7.3 Driving and Restraining Forces Influencing the Biobanking Market for Therapeutic Applications, 2015-2025
4. Biobanking for Research Purposes
4.1 Breakdown of the Biobanking for Research Market by Tissue Type, 2014
4.2 Biobanking for Research in 2019 and 2025: Comparison by Tissue Type
4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts 2015-2025
4.4 How Many Specimens are Biobanked for Research?
4.5 The Human Tissue Banking Market for Research in 2014
4.6 The Human Tissue Banking Market for Research: Revenue Forecast 2015-2025
4.7 The Human Tissue Banking Market: Commercial vs. Public Sector
4.7.1 Commercial Human Tissue Banks: Revenue Forecast 2015-2025
4.7.2 Public Sector Human Tissue Banks: Revenue Forecast 2015-2025
4.8 The Stem Cell Banking Market for Research in 2014
4.9 The Stem Cell Banking Market for Research: Revenue Forecast 2015-2025
4.9.1 RandD - Growing Interest towards iPSCs
4.10 Banking of Other Biologic Specimens for Research in 2014
4.11 Banking of Other Biologic Specimens for Research: Revenue Forecast 2015-2025
5. Stem Cell Banking for Future Therapeutic Use
5.1 Stem Cell Banking for Therapeutic Use in 2014: A Breakdown by Stem Cell Type
5.2 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenue and Market Share, 2019 and 2025
5.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Grouped Revenue Forecasts
5.4 How Many Stem Cell Samples Are Biobanked Each Year?
5.5 The Umbilical Cord Blood Banking Market in 2014
5.5.1 Private vs. Public Cord Blood Banking
5.5.2 Umbilical Cord Blood Banking: The Controversies
5.6 The Umbilical Cord Blood Banking Market: Revenue Forecast 2015-2025
5.7 The Adult Stem Cell Banking Market in 2014
5.8 The Adult Stem Cell Banking Market: Revenue Forecast 2015-2025
6. Leading National Markets 2015-2025
6.1 The Geographical Footprint of Biobanking
6.1.1 Biobanking in Europe: Leading the World with Biobanking Networks and Infrastructure
6.1.2 Biobanks in the US: A Fragmented Picture
6.1.3 Biobanking in Asia: A Region Fast Gaining Prominence
6.2 Biobanking for Medicine: The US Led the Way in 2014
6.3 The Leading National Markets: Grouped Revenue Forecasts 2015-2025
6.4 How Will Regional Market Shares Change to 2025?
6.5 The US Biobanking Market 2014-2024: Diversifying and Expanding
6.6 The Top European Biobanking Markets 2015-2025: Leading the Way in Biobanking Infrastructure
6.6.1 Germany: An Advanced Industry with 74 Biobanks Associated with the BBMRI
6.6.2 France: Restrictions on Private Stem Cell Banking Limit the Market
6.6.3 Italy: Is the Limited Private Stem Cell Banking Market Off-Set by Strong Biobanking Networks for Research?
6.6.4 UK: Limited Presence of Biobanking Networks
6.6.5 Spain: Controversy Between Private and Public Umbilical Cord Blood Banks
6.6.6 The Netherlands is Characterised by Comprehensive Biobanking Networks
6.7 The Japanese Biobanking Market 2015-2025: A High Level of Government Investment Drives Growth
6.8 The Biobanking Industry in the BRIC Countries: High Growth and Increasing Market Share between 2015 and 2025
6.8.1 The Chinese Biobanking Market 2015-2025: The High Rate of Growth Will Continue
6.8.2 The Indian Biobanking Market 2015-2025: Set to Become the Leading Market for Private Stem Cell Banking?
6.8.3 The Brazilian Biobanking Market 2015-2025: Will New Regulations Drive or Restrain the Market?
6.8.4 Russia: Ban on the Import and Export of Human Tissue and Genetic Information Restricts the Market, But Can This Be Overcome from 2015-2025?
7. Technology for Biobanking: Systems, Software, Consumables and Services Associated With Biobanking
7.1 The Biobanking-Associated Market: Overview
7.2 Systems Technology: Fully Automated Handling
7.2.1 Automated Liquid Handling Systems
7.2.2 Frozen Aliquoting: Patented Technology from CryoXtract
7.2.3 Automated DNA Isolation
7.3 Storage Technology: Sustainability and Easy Sample Tracking
7.3.1 Dry State, Room Temperature Storage Eliminates the Need for Expensive, Energy-Consuming Freezers
7.3.2 Ultra-Low Temperature Freezers: Is Their Use Declining?
7.3.3 Cryopreservation: Mechanical vs. Liquid/ Vapour Phase Nitrogen
7.3.4 Automated Storage and Retrieval Systems: Essential Technology
7.3.5 RFID and Tagging Technology: Advantages over Barcodes
7.4 Software for Biobanks
7.4.1 Laboratory Information Management System (LIMS): Unmet Needs in the Market Remain, Despite Recent Advances
7.4.2 LIMS Functions
7.5 Consumables: High Quality Required for Effective Sample Management
7.5.1 Addressing Sample Storage and Tracking Issues
7.6 Biobanking Services: Storage, Management and Transport of Biologic Samples for a Fee
8. Leading Companies in the Biobanking Market
8.1 The Differing Business Models of Biobanking Companies: Sourcing vs. Storing
8.2 Commercial Biobanks for Research Purposes in 2014
8.2.1 Tissue Solutions: A Virtual Biobank with a Global Presence
8.2.1.1 An Overview of the Products and Services Offered by Tissue Solutions
8.2.1.2 Banked Samples Occur in Many Formats
8.2.1.3 Prospective Tissue Collection for Hard-to-Find Samples
8.2.1.4 Fresh Samples from Surgical Resections are in High Demand
8.2.1.5 Freshly Isolated Human Cells are a Valuable Research Tool
8.2.1.6 FDA/ EMA Panel of Normal Tissues
8.2.1.7 Strengths, Capabilities and the Future Outlook for Tissue Solutions
8.2.2 Asterand is now Part of Stemgent
8.2.2.1 Asterand's Products and Services: XpressBANK, ProCURE and PhaseZERO
8.2.3 Biopta Provides Fresh Human Tissues, for Which Demand is Growing
8.2.3.1 Services from Biopta: Fresh Tissue Sample Procurement and a Variety of Lab Services
8.2.3.2 The First Catalogue of Assays Based on Human Functional Tissues
8.2.3.3 The Future Outlook for Biopta
8.2.4 BioServe: One of the World's Largest Commercial Biorepositories
8.2.4.1 BioServe Offers a Comprehensive List of Services: Biobanking, Sourcing and Preclinical Molecular Services
8.2.4.2 The Future Outlook for BioServe
8.2.5 Coriell Institute for Medical Research: Reportedly the Largest Biobank in the World
8.2.5.1 Features of Coriell Biobank
8.2.5.2 Future Outlook for the Coriell Biobank
8.3 Prominent Biobanks for Therapeutic Use in 2014
8.3.1 Cord Blood America: Expansion into the Emerging Markets Apparently Stalled
8.3.2 Cryo-Cell International: The First Private Cord Blood Bank in the Market
8.3.3 Cryo-Save's Educational Programme Benefits Company's Growth
8.3.4 China Cord Blood Corp: The Only Cord Blood Bank in China with Multiple Licences
8.3.5 LifebankUSA: Placental and Cord Blood Banking Means a Significant Survival Advantage in Transplant Patients
8.3.6 ViaCord: More Blood Units Released for Therapy than Any Other Family Bank
8.3.7 Cord Blood Registry: The World's Largest Newborn Stem Cell Company, Accounting for 3% of the Private Stem Cell Banking Industry
8.3.8 Biogenea Pharmaceuticals: A Comprehensive Offering of Stem Cell Banking Services across the Balkan Peninsula
8.3.9 StemLife is Facing Challenges due to Government Regulations in Malaysia
8.3.10 Future Health Biobank: A Strong Market Presence Owing to International Operations
8.3.11 NeoStem Operates a Multi-Faceted Business Strategy
8.3.12 Precious Cells is Well Positioned to Take Advantage of the Growing Demand in India
9. Qualitative Analysis of the Biobanking Industry and Market 2015-2025
9.1 Industry Trends
9.1.1 The Growing Demand for Biobank Resources for Research
9.1.2 The Establishment of Biobanking Networks
9.1.2.1 BBMRI: The Most Extensive Biobank Network
9.1.3 Virtual Biobanks: Connecting a Fragmented Industry
9.1.4 Commercial Biobanks as Intermediaries: New Resources for Research
9.1.5 Automated Biobanking Has Become Imperative
9.1.6 Increasing Uptake of LIMS
9.1.7 Green Banking - Becoming More Energy Efficient
9.2 The Strengths and Weaknesses of the Biobanking Market in 2014
9.2.1 HBS are Valuable Resources for RandD
9.2.2 Governmental Support for Biobanking Forms a Strength of that Industry
9.2.3 Development of Potential Novel Stem Cell Therapies has Increased Public Awareness of Stem Cell Banking
9.2.4 Insufficient Accessible Numbers of High Quality Biospecimens
9.2.5 Biobanks are Fragmented and Uncoordinated
9.2.6 Lack of Standardisation is a Weakness of the Industry
9.2.7 Lack of Public Awareness Limits Number of Donors
9.2.8 Lack of Engagement with Public Health Services Limits the Stem Cell Banking Market
9.3 Opportunities and Threats Facing the Biobanking Market, 2015-2025
9.3.1 Increasing Use of Biobanked Specimens in Genome-Wide Association Studies (GWAS)
9.3.2 Increasing Demand for Biobanked Samples for Preclinical Research
9.3.3 Biobanking Networks as a Basis for Personalised Medicine
9.3.4 Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
9.3.5 Even With Governmental Funding, Biobanks Must Become Self-Sufficient to Thrive Long Term
9.3.6 Public Concerns over Confidentiality and Security Threaten Availability of Donors
9.3.7 Limitations Surrounding Informed Consent
9.4 Social, Technological, Economic and Political Factors (STEP) Influencing the Biobanking Industry, 2015-2025
10. Research Interviews from Our Survey - 2015
10.1 Dr Jeanne-Helene di Donato, 3C-R, France
10.1.1 French Biobanks - a Network of Specialized Biobanks
10.1.2 Biobanking Management -Promoting Scientific Value of Collections
10.1.3 Harmonization - Scientific Valorisation
10.1.4 Bioethical - Diverse Views and Policies on Consent
10.1.5 Broad Consent -Is This the Best Option?
10.1.6 3C-R - Services and Solutions for Biobanks
10.2 Dr Luis Nacul and Dr Eliana Lacerda, UK ME/CFS Biobank Project
10.2.1 UK ME/CFS Biobank - Objectives and Activities
10.2.2 Biobank Resource - Available for External Researchers in August 2015
10.2.3 Main Issue - Sustainability
10.2.4 Unmet Needs - Awareness from Government and General Public
11. Conclusions from the Research and Analysis
11.1 World Biobanking Market 2015-2025: High Revenue Growth Predicted
11.2 Biobanking for Research 2015-2025: The Value of Biobanked Specimens is Increasingly Recognised
11.3 Biobanking for Therapeutic Use 2015-2025: Rapid Expansion in Adult Stem Cell Banking
11.4 The Leading National Markets: High Sales Growth Worldwide
11.5 Current and Future Trends in Biobanking
11.5.1 Increasing Demand for Biobanked Samples - Increasing Revenue
11.5.2 Improving Biobanking Infrastructure - Growth Driver
11.5.3 Marked Challenges, but Opportunities for Expansion

List of Tables
Table 1.1 Biobanking for Medicine by Sector: Grouped Revenue Forecasts ($bn), 2014-2025
Table 2.1 Prominent Population-Based Biobanks, 2014
Table 2.2 Prominent Disease-Based Biobanks, 2014
Table 2.3 Guidelines and Recommendations for Biobanks, 2014
Table 2.4 Laws and Other Regulations for Biobank-Based Research by Country/ Organisation 2014
Table 2.5 Pharmaceutical and Biotechnology Companies with In-House Biobanks, 2014
Table 3.1 Breakdown of the Biobanking Industry by Research vs. Therapeutics: Revenue ($bn) and Market Share (%), 2014
Table 3.2 Breakdown of the Biobanking Industry by Research vs. Therapeutics: Comparison of Revenues ($bn) and Market Shares (%), 2019 and 2025
Table 3.3 Biobanking for Medicine: Overall World Revenue Forecast ($bn), 2014-2025
Table 3.4 The Number of Samples Stored in Biobanks by Purpose (m): Forecasts (m), 2014-2025
Table 3.5 Biobanking for Medicine by Sector: Grouped Revenue Forecasts ($bn), 2014-2025
Table 3.6 Biobanking Market for Research: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 3.7 Biobanking for Therapeutic Use: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 4.1 The Biobanking for Research Market by Tissue Type: Revenues ($bn) and Market Shares (%), 2014
Table 4.2 Biobanking for Research by Tissue Type: A Comparison of Revenues ($bn) and Market Shares (%), 2019 and 2025
Table 4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts ($bn), 2014-2025
Table 4.4 Number of Research Samples Banked (m): Forecast 2014-2025
Table 4.5 The Human Tissue Banking Market: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 4.6 The Commercial vs. Public Sector Human Tissue Banking Market: Comparison of Revenues ($bn) and Market Shares (%), 2014, 2019 and 2025
Table 4.7 The Human Tissue Banking Market by Subsector: Revenue Forecasts ($bn), 2014-2025
Table 4.8 Commercial Human Tissue Banking: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 4.9 Prominent Commercial Human Tissue Banks, 2014
Table 4.10 Public Sector Human Tissue Banking: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 4.11 Prominent Public-Funded Human Tissue Banks, 2014
Table 4.12 The Stem Cell Banking Market for Research: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 4.13 Prominent Stem Cell Banks Serving the Research Community, 2014
Table 4.14 Banking of Other Biologic Specimens for Research: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 4.15 Prominent Biobanks Storing Other Biologic Samples, 2014
Table 5.1 Biobanking for Therapeutic Use by Stem Cell Type: Revenues ($bn) and Market Shares (%), 2014
Table 5.2 Biobanking for Therapeutic Use by Stem Cell Type: Comparison of Revenues ($bn) and Market Shares (%), 2019 and 2025
Table 5.3 Biobanking for Therapeutic Use by Stem Cell Type: Grouped Revenue Forecasts ($bn), 2014-2025
Table 5.4 The Number of Stem Cell Samples Banked for Therapeutic Use (m): Forecast 2014-2025
Table 5.5 Prominent Public and Private Cord Blood Banks, 2014
Table 5.6 The Umbilical Cord Banking Market: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 5.7 Prominent Companies in the Adult Stem Cell Banking Industry, 2014
Table 5.8 The Adult Stem Cell Banking Market: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 6.1 Breakdown of the Number of Biobanks Associated with BBMRI by Country, 2014
Table 6.2 The Leading National Biobanking Markets: Comparison of Revenues ($bn) and Market Shares (%), 2014
Table 6.3 Leading National Markets: Grouped Revenue Forecasts ($bn), 2014-2025
Table 6.4 Leading National Markets: Comparison of Market Shares (%), 2014, 2019 and 2025
Table 6.5 Biobanking for Medicine in the US: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 6.6 The Leading European Markets for Biobanking: Grouped Revenue Forecasts ($bn), 2014-2025
Table 6.7 Examples of Biobanking Initiatives Funded by the European Commission
Table 6.8 The German Biobanking Industry: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 6.9 The French Biobanking Industry: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 6.10 The Italian Biobanking Industry: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 6.11 The UK Biobanking Industry: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 6.12 The Spanish Biobanking Industry: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 6.13 Prominent Clinical and Population Biobanks in the Netherlands
Table 6.14 The Netherlands Biobanking Industry: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 6.15 The Japanese Biobanking Industry: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 6.16 The Biobanking Industry in the BRIC Countries: Grouped Revenue ($bn) and Market Share (%) Forecasts, 2014-2025
Table 6.17 The Chinese Biobanking Industry: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 6.18 The Indian Biobanking Industry: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 6.19 Prominent Research Biobanks in India, 2014
Table 6.20 The Brazilian Biobanking Market: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 6.21 The Russian Biobanking Industry: Revenue ($bn) and Market Share (%) Forecast, 2014-2025
Table 7.1 Prominent Companies Providing Automated Liquid Handling Technology, 2014
Table 7.2 Prominent Companies Providing Room Temperature Storage Solutions, 2014
Table 7.3 Prominent Companies Providing Ultra-Low Temperature Freezers (-80°C), 2014
Table 7.4 Mechanical Freezing vs. Liquid Nitrogen: Comparison of Advantages and Disadvantages, 2014
Table 7.5 Prominent Companies Providing Cryogenic Storage Solutions, 2014
Table 7.6 Prominent Providers of Automated Biobanking Systems, 2014
Table 7.7 Major Vendors in the LIMS Market, 2014
Table 7.8 Prominent Vendors of Consumables for Biobanking, 2014
Table 7.9 Prominent Biorepository Service Providers, 2014
Table 8.1 Prominent Players in the Biobanking Industry for Research, 2014
Table 8.2 Prominent Companies in the Stem Cell Banking Industry for Therapeutic Use, 2014
Table 8.3 China Cord Blood Corp: Revenue ($m) and Number of Subscribers, 9 Months Ended Dec. 2013 and 2014
Table 8.4 StemLife: Comparison of Revenue ($m) between 2013 and 2014
Table 9.1 Strengths and Weaknesses of the Biobanking Industry, 2014
Table 9.2 Opportunities and Threats Facing the Biobanking Industry, 2015-2025
Table 9.3 Social, Technological, Economic and Political (STEP) Forces Influencing the Biobanking Industry, 2015-2025

List of Figures
Figure 2.1 Processes Involved in Biobanking, 2014
Figure 2.2 The Classification of Biobanks, 2014
Figure 3.1 Breakdown of the Biobanking Industry by Research vs. Therapeutics: Market Shares (%), 2014
Figure 3.2 Breakdown of the Biobanking Industry by Research vs. Therapeutics: Market Shares (%), 2019
Figure 3.3 Breakdown of the Biobanking Industry by Research vs. Therapeutics: Market Shares (%), 2025
Figure 3.4 Biobanking for Medicine: Overarching Revenue Forecast ($bn), 2014-2025
Figure 3.5 The Number of Samples Stored in Biobanks by Purpose: Forecasts (m), 2014-2025
Figure 3.6 Biobanking for Medicine by Sector: Grouped Revenue Forecasts ($bn), 2014-2025
Figure 3.7 Biobanking Market for Research: Revenue Forecast ($bn), 2014-2025
Figure 3.8 Biobanking for Research: Drivers and Restraints, 2015-2025
Figure 3.9 Biobanking for Therapeutic Use: Revenue Forecast ($bn), 2014-2025
Figure 3.10 Biobanking for Therapeutic Use: Drivers and Restraints, 2015-2025
Figure 4.1 The Biobanking for Research Market by Tissue Type: Market Shares (%), 2014
Figure 4.2 Biobanking for Research by Tissue Type: Market Shares (%), 2019
Figure 4.3 Biobanking for Research by Tissue Type: Market Shares (%), 2025
Figure 4.4 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts ($bn), 2014-2025
Figure 4.5 Biobanking for Research: Market Drivers and Restraints, 2015-2025
Figure 4.6 Number of Research Samples Banked (m): Forecast, 2014-2025
Figure 4.7 The Human Tissue Banking Market: Revenue Forecast ($bn), 2014-2025
Figure 4.8 Human Tissue Banking for Research: Market Drivers and Restraints, 2015-2025
Figure 4.9 The Commercial vs. Public Sector Human Tissue Banking Market: Market Shares (%), 2014
Figure 4.10 The Commercial vs. Public Sector Human Tissue Banking Market: Market Shares (%), 2019
Figure 4.11 The Commercial vs. Public Sector Human Tissue Banking Market: Market Shares (%), 2025
Figure 4.12 The Human Tissue Banking Market by Subsector: Revenue Forecasts ($bn), 2014-2025
Figure 4.13 Commercial Human Tissue Banking: Revenue Forecast ($bn), 2014-2025
Figure 4.14 Public Sector Human Tissue Banking: Revenue Forecast ($bn), 2014-2025
Figure 4.15 The Stem Cell Banking Market for Research: Revenue Forecast ($bn), 2014-2025
Figure 4.16 Stem Cell Banking for Research: Market Drivers and Restraints, 2015-2025
Figure 4.17 Banking of Other Biologic Specimens for Research: Revenue Forecast ($bn), 2014-2025
Figure 4.18 Biobanking of Other Biologic Specimens for Research: Market Drivers and Restraints, 2015-2025
Figure 5.1 Biobanking for Therapeutic Use by Stem Cell Type: Market Shares (%), 2014
Figure 5.2 Biobanking for Therapeutic Use by Stem Cell Type: Market Shares (%), 2019
Figure 5.3 Biobanking for Therapeutic Use by Stem Cell Type: Market Shares (%), 2025
Figure 5.4 Biobanking for Therapeutic Use by Stem Cell Type: Grouped Revenue Forecasts ($bn), 2014-2025
Figure 5.5 The Number of Stem Cell Samples Banked for Therapeutic Use (m): Forecast 2014-2025
Figure 5.6 The Stem Cell Banking Market for Future Therapeutic Use: Drivers and Restraints, 2015-2025
Figure 5.7 The Umbilical Cord Banking Market: Revenue Forecast ($bn), 2014-2025
Figure 5.8 The Umbilical Cord Blood Banking Market: Drivers and Restraints, 2015-2025
Figure 5.9 The Adult Stem Cell Banking Market: Revenue Forecast ($bn), 2014-2025
Figure 5.10 The Adult Stem Cell Banking Market: Drivers and Restraints, 2015-2025
Figure 6.1 The Leading National Biobanking Markets: Market Shares (%), 2014
Figure 6.2 The Leading National Markets: Grouped Revenue Forecasts ($bn), 2014-2025
Figure 6.3 The Leading National Markets: Market Shares (%), 2014
Figure 6.4 The Leading National Markets: Market Shares (%), 2019
Figure 6.5 The Leading National Markets: Market Shares (%), 2025
Figure 6.6 Biobanking for Medicine in the US: Revenue Forecast ($bn), 2014-2025
Figure 6.7 Driving and Restraining Factors of the US Biobanking Market, 2015-2025
Figure 6.8 The Leading European Markets for Biobanking: Grouped Revenue Forecasts ($bn), 2014-2025
Figure 6.9 Biobanking in the Leading European Countries: Driving and Restraining Factors, 2015-2025
Figure 6.10 The German Biobanking Industry: Revenue Forecast ($bn), 2014-2025
Figure 6.11 The French Biobanking Industry: Revenue Forecast ($bn), 2014-2025
Figure 6.12 The Italian Biobanking Industry: Revenue Forecast ($bn), 2014-2025
Figure 6.13 The UK Biobanking Industry: Revenue Forecast ($bn), 2014-2025
Figure 6.14 The Spanish Biobanking Industry: Revenue Forecast ($bn), 2014-2025
Figure 6.15 The Netherlands Biobanking Industry: Revenue Forecast ($bn), 2014-2025
Figure 6.16 The Japanese Biobanking Industry: Revenue Forecast ($bn), 2014-2025
Figure 6.17 Driving and Restraining Factors Influencing the Japanese Biobanking Industry, 2015-2025
Figure 6.18 The Biobanking Industry in the BRIC Countries: Grouped Revenue Forecasts ($bn), 2014-2025
Figure 6.19 Driving and Restraining Factors of the Biobanking Industry in the BRIC Countries, 2015-2025
Figure 6.20 The Chinese Biobanking Industry: Revenue Forecast ($bn), 2014-2025
Figure 6.21 The Indian Biobanking Industry: Revenue ($bn) Forecast, 2014-2025
Figure 6.22 The Brazilian Biobanking Market: Revenue Forecast ($bn), 2014-2025
Figure 6.23 The Russian Biobanking Industry: Revenue Forecast ($bn), 2014-2025
Figure 7.1 Structure of the Biobanking Industry: Biobanking-Associated Market, Biobanks and End Users, 2014
Figure 7.2 The Basic Function of LIMS
Figure 8.1 Biobanking Business Model: Commercial Sourcing of Biological Samples, 2014
Figure 8.2 Business Model: Commercial Banking of Biological Samples, 2014
Figure 8.3 China Cord Blood Corp: Revenue ($m) and Number of Subscribers, 9 Months Ended Dec. 2013 and 2014
Figure 8.4 StemLife: Comparison of Revenue ($m), 2013 and 2014
Figure 11.1 The Global Biobanking Market by Industry Sector: Comparison of Revenues ($bn), 2014, 2019 and 2025
Figure 11.2 Biobanking for Research by Sample Type: Comparison of Revenues ($bn), 2014, 2019 and 2025
Figure 11.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenues ($bn), 2014, 2019 and 2025
Figure 11.4 Leading Regional Markets for Biobanking: Comparison of Revenues ($bn), 2014, 2019 and 2025

Companies Listed
3C-R
Abbott Laboratories
Accelrys
Adnexus Therapeutics
Advanced Innovative Medicine
AIS
AKH Biobank
AllCells
Allied Minds
AlloSource
American Association of Tissue Banks
American CryoStem
American Type Culture Collection (ATCC)
Amgen
Analytical Biological Services
ARUP Laboratories
ASPREE Healthy Ageing Biobank
AssureImmune
AstraZeneca
Aurora Biomed
Australian Biospecimen Network (ABN)
Autoscribe Informatics
AuxoCell Laboratories
AXM Shenyang
Bangalore Brain Bank
Barts Gynae Tissue Bank
Bavarian Red Cross (BRK)
Bayer
BBMRI
Beckman Coulter
BINDER
Biobank Ireland Trust
BioFortis
Biogen Idec
Biogenea
Biogenea Pharmaceuticals
BioLife Solutions
Biomatrica
Biomedical Research Council (BMRC)
Biopta
BioRep
BioRepository Resources
BioStorage Technologies
Biovault Technical
Bluechiip Ltd.
BrainNet Europe
Bristol-Myers Squibb
Brooks
Brooks Life Science Systems
Cambridge Biomedical Research Centre
Cambridge Biosciences
Canadian Partnership for Tomorrow
Cancer Genetics Inc
Cancer Genetics India
Cancer Human Biobank (caHUB)
CCLG Tissue Bank
Celgene
Cells4Life
Celltex Therapeutics
Cellular Dynamics
Centro Nazionale per le Risorse Biologiche (CNRB)
Chernobyl Tissue Bank
China Cord Blood Corp.
China Kadoorie Biobank
China Stem Cells
CLB/Amsterdam Medical Center
CMD Biobank
CONCOR
CorCell
Cord Blood Registry (CBR)
CordBlood America
CordLife
CordVida
CORE Informatics
Coriell Institute for Medical Research
Council of Europe (CoE)
Covance
Cryo Bio System
Cryo Save
Cryo-Cell International
Cryogene Lab
CryoLogic
Cryopraxis
CryoXtract Instruments
Cureline
Custom Biogenic Systems
Cybrdi
Daifuku
Danubian Biobank Consortium
deCODE Genetics
Department of Health and Scottish Government
Eli Lilly
EMA
Eppendorf
Esco
European Commission (EC)
European Health Risk Monitoring (EHRM)
European Research Infrastructure Consortium (ERIC)
European Union Group on Ethics (EGE)
FDA
Fisher BioServices
FluidX
Future Health Biobank
GC Biotech
GE Healthcare
GE Healthcare SeqWright Genomic Services
Genentech
GenVault
Gilson
GlaxoSmithKline
Hamilton
Hamilton Robotics
Hamilton Storage Technologies
Harvard Stem Cell Institute
Hospital Necker Paris
Hudson Robotics
Human Science Research Resource Bank (HSRRB)
Human Tissue Bank
Hungarian Biobank
Huntington Disease Biobank
ILSBio
Imperial Tissue Bank
Inbiomed
Indian Institute of Technology
Indivumed
Infectious Disease Biobank
INSERM
Instituto de Salud Carlos III (ISCIII)
IntegenX
International Agency for Research on Cancer (IARC)
International Organization for Standardization
International Society for Biological and Environmental Repositories (ISBER)
International Stem Cell Corporation
Japan Health Sciences Foundation
Kaiser Permanente
King's College London Tissue Bank
KORAgen
Labtech
LABVANTAGE
Labware
LBD Life Sciences
Leiden Longevity
Leiden University Medical Center
LifeBank USA
LifeGene
LifeLines Biobank
Malmo Microbiology Biobank
MatriCal Biosciences
Medical Research Council
Merck
Micronic
Ministry of Health and Welfare
Mitochondrial Disease Biobank
MSD
Narayana Hrudayalaya Tissue Bank and Stem Cell Research Center
National Cancer Institute (NCI)
NeoStem
NESDA
Netherlands Twin Registry
NHS Blood and Transplant Cord Blood Bank
Northwest Regional Development Agency
Novare Biologistics
Novartis
Office of Biorepositories and Biospecimen Research (OBBR)
OnCore UK
Organisation for Economic Co-operation and Development (OECD)
OriGene
Pacific BioStorage
PALGA
Panasonic Biomedical
Parelsnoer
Perkin Elmer
Pfizer
Pharma Cells
Pop-Gen National Cohort
Precious Cells
Precision Bioservices
PrecisionMed
PREVEND
Progenicyte
Progenitor Cell Therapy (PCT)
ProMedDx
Promega
ProteoGenex
Provia Labs
Qiagen
RAND
ReproCELL Group
Riken BRC Cell Bank
Roche
Rotterdam Study
RTS Life Sciences
Russian Society of Personalised Medicine (RSPM)
Sapien Biosciences
Sceil
Seattle Genetics
Sechenov First Moscow Medical University (SFMMU)
Singapore Biobank (SBB)
Singapore Cord Blood Bank
Singapore Tissue Network (STN)
Smart Cells
Spanish Ministry of Science and Innovation (MICINN)
Spanish National Biobank Network
Stanford Tissue Bank
StarLIMS
Steelgate
Stellacure
Stem Cells for Safer Medicine
Stemcyte
Stemgent
StemLife
StemSave
Swedish Institute for Infectious Disease Control Biobank
System Biosciences
Taiyo Nippon Sanso
TAP Biosystems
Tata Memorial Hospital Tissue Bank
TCG Life Sciences Tissue Bank
Tecan
The Cambridge Brain Bank
The Guangzhou Biobank
The National Cancer Tissue Bank
Thermo Genesis
Thermo Scientific
Tissue Solutions
Titan Pharmaceuticals
TTP Labtech
UCL Biobank
UK Biobank
UK ME-CFS Biobank
UK Multiple Sclerosis Tissue Bank
UK Parkinson's Disease Tissue Bank
UK Stem Cell Bank
University of Tuebingen
US Biomax
US Department of Transportation's (DOT's)
V.A. Almazov Federal Center for Heart, Blood and Endocrinology
ViaCord
VidaPlus
Virgin Health Bank
Wellcome Trust
Wheaton
Wisconsin International Stem Cell (WISC) Bank
World Health Organization (WHO)
Wyeth

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Global Biobanking Market 2015-2019

Global Biobanking Market 2015-2019

  • $ 2 500
  • Industry report
  • April 2015
  • by Infiniti Research Limited

About Biobank Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different ...

MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

This BCC Research report provides an overview of the current state of the microRNA (miRNA) market, focusing mainly on continuing research endeavors, newly emerging sophisticated tools, reagents, techniques, ...

Next-Generation Sequencing: Emerging Clinical Applications and Global Markets

Next-Generation Sequencing: Emerging Clinical Applications and Global Markets

  • $ 6 650
  • Industry report
  • June 2015
  • by BCC Research

This BCC Research report provides a comprehensive discussion of NGS technologies, clinical applications, industry structure, important clinical sequencing initiatives, global markets, patent status and ...


Download Unlimited Documents from Trusted Public Sources

Genomics Industry in Canada

  • January 2015
    34 pages
  • Genomics  

  • Canada  

View report >

Genetic Industry in the US

  • January 2015
    68 pages
  • Genetic  

  • United States  

View report >

Pathology Description in the Netherlands

  • January 2015
    7 pages
  • Mental Illness  

  • Netherlands  

View report >

Fish Industry

8 months ago

Related Market Segments :

Biobanking

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.